MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Explore our core ISO-certified disposable medical device portfolio engineered for global clinical compliance and procurement efficiency.
Precision-manufactured peripheral IV catheters available in 14G through 26G. Features ISO colour-coded hubs, siliconised tri-facet bevelled needles, and radio-opaque FEP/PUR catheter tubing for smooth, atraumatic insertion.
Sterile, single-use intravenous catheters designed for inpatient and outpatient care. Integrated with Japanese stainless steel needles and medical-grade blister packaging for maximum sterility maintenance during global transport.
Specialised winged butterfly intravenous catheter designed for veterinary infusion and fluid stabilization. Engineered for high flexible stability during small animal fluid therapy and blood draws.
CE & ISO 13485 compliant 18G butterfly catheter equipped with an integrated injection port and non-return valve, allowing needle-free bolus medication delivery without disrupting main infusions.
Fine-gauge veterinary IV cannula line (22G, 24G, 26G) tailored for canine and feline clinical treatments. Features flexible, kink-resistant tubing that minimises vein irritation in active animal patients.
B2B wholesale medical sterile IV catheter featuring an ultra-clear blood flashback chamber for instant visual confirmation of successful venipuncture, mitigating haematoma risks in high-turnover emergency units.
Advanced safety-engineered veterinary IV catheter (22G & 24G) equipped with a self-activating passive safety clip. Encapsulates sharp needle tips instantly upon withdrawal to eliminate needle-stick risks for clinical staff.
Complete B2B supply of veterinary IV access devices spanning 14G to 26G. Designed for both livestock and companion animals with medical-grade plastic, smooth stylet withdrawal, and flexible fixing wings.
In modern global healthcare procurement, the demand for high-integrity, sterile single-use hypodermic syringes and intravascular access consumables has evolved far beyond basic cost-per-unit evaluation. Hospital purchasing consortiums, national ministry of health tenders, and international medical device distributors now demand rigorous compliance with ISO 7886-1, ISO 80369-7, ISO 13485:2016, and European Medical Device Regulation (EU MDR 2017/745).
As a vertically integrated original equipment manufacturer (OEM) and original design manufacturer (ODM), our production ecosystem operates under a unified cleanroom framework. Every step—from virgin polypropylene polymer compounding and micro-precision needle grinding to ethylene oxide (EO) sterilisation validation—is executed under strict quality management systems (QMS) to guarantee zero-defect performance at the point of clinical care.
Unlike third-party trading intermediaries, direct factory-source manufacturing ensures total traceability from raw polymer resin to final sterilized blister pouch. Our facilities employ fully automated vision inspection systems (AOI) to verify needle bevel geometry, silicone coating uniformity, barrel graduation ink adhesion, and dead-space volume limits across millions of units produced monthly.
Comprehensive breakdown of key structural, material, and operational specifications for our OEM/ODM hypodermic syringe and IV cannula product families:
| Device Family | Primary Material Standard | Key Features & Options | Sterilisation Method | Regulatory Compliance |
|---|---|---|---|---|
| 2-Part Hypodermic Syringes | Medical-grade Polypropylene (Barrel & Plunger) | Luer Slip / Luer Lock, clear barrel scale, low dead space design | Ethylene Oxide (EO) / Gamma | CE Mark, ISO 7886-1, ISO 13485 |
| 3-Part Hypodermic Syringes | Polypropylene + Synthetic Rubber Gasket (Latex-Free) | Dual-ring gasket seal, zero friction plunger travel, mounted needle option | Ethylene Oxide (EO) | CE Mark, ISO 7886-1, ISO 10993 |
| Safety IV Cannula (Passive) | Radio-opaque FEP / PUR Catheter + SS Needle | Automatic needle tip shield, blood flashback control, injection port | Ethylene Oxide (EO) Validation | CE 0123, ISO 10555-1, ISO 10555-5 |
| Veterinary IV Catheters | High-flex Polyurethane (PUR) + Color-Coded Hubs | Winged butterfly, 14G–26G sizing, animal-friendly fixation ergonomics | Ethylene Oxide (EO) | ISO 13485:2016 Certified |
Our purpose-built manufacturing complex in Sonepat, Haryana (India), backed by global administrative offices in New Delhi and Milton (Canada), guarantees total control over the single-use medical disposable lifecycle.
We operate an advanced tool room capable of custom mould fabrication, needle tip bevel micro-grinding, and barrel graduation design. OEM partners can specify custom volumetric increments, hub colors, and plunger actuation forces without relying on external vendors.
Conducted inside ISO Class 8 environmentally controlled cleanrooms with positive pressure filtration, humidity regulation, and airborne particle monitoring to eliminate microbial contamination risks prior to primary blister sealing.
State-of-the-art EO sterilisation chambers validated in complete compliance with ISO 11135. Every batch undergoes strict biological indicator (BI) verification and gas residue analysis to guarantee a Sterility Assurance Level (SAL) of 10⁻⁶.
Strategic purchasing managers and medical device importers must align their supply chains with incoming global regulatory mandates, safety guidelines, and environmental standards. Our analysis reveals four dominant procurement shifts that will shape the single-use medical disposable landscape over the coming decade:
Global health authorities—including the WHO, US OSHA, and European Union directives—are making safety-engineered sharps injury protection (SESIP) devices mandatory in public healthcare systems. Importers are rapidly shifting orders from traditional IV cannulas and syringes toward passive retractable syringes and auto-shielding IV catheters that automatically protect clinicians from blood-borne pathogen exposure without requiring manual activation steps.
Concerns surrounding phthalate toxicity (specifically DEHP leachable substances) in pediatric, neonatal, and oncology patient care have led to strict bans across major markets. Future procurement contract criteria heavily favor suppliers capable of offering 100% DEHP-free, latex-free, and PVC-free polyolefin infusion lines and syringe components that meet biocompatibility testing per ISO 10993 standards.
Under EU MDR and US FDA regulations, device trace-ability is paramount. B2B buyers now mandate that OEM manufacturers incorporate GS1-compliant 2D DataMatrix codes, UDI barcoding, and standardized multi-lingual Instructions for Use (IFU) directly onto primary blister packages and secondary shelf cartons to streamline hospital inventory management.
The global single-use syringe market is undergoing consolidation around manufacturers who maintain authentic, unannounced audit-ready quality systems. Key developmental drivers include:
Clear technical and commercial answers for healthcare distributors, hospital purchasing officers, and OEM brand owners.
Every shipment is supported by a comprehensive technical documentation dossier. This includes CE Mark certification, ISO 13485:2016 Quality Management Certification, EC Declaration of Conformity, Certificate of Free Sale (CFS), batch-specific Certificate of Analysis (CoA), EO sterilisation validation logs, bioburden test reports, and non-pyrogenicity test certificates. Technical files are structured in STED format to facilitate smooth registration with national regulatory authorities in Africa, Latin America, the CIS region, South-East Asia, and Europe.
We provide complete OEM/ODM solutions tailored to distributor requirements. Capabilities include customized brand artwork printing on medical-grade blister paper, custom shelf boxes, multi-lingual Instructions for Use (IFU), specialized barrel scale printing (e.g., dual ml/Insulin units), custom gauge combinations, color-coded components, and UDI barcode integration. Because tool-making and moulding are performed in-house, custom structural requests can be implemented efficiently.
For standard catalogue items in neutral export packaging, order quantities can start at one consolidated pallet. For customized OEM private-label programs, MOQs are set on a per-SKU basis depending on printing matrix requirements (typically 50,000 to 100,000 units per gauge). Lead times for repeat catalogue orders average 3 to 4 weeks, while initial OEM programs require 5 to 7 weeks to allow artwork proofing, plate setup, cleanroom assembly, and EO sterilisation validation cycles.
Yes. All syringe gaskets, catheter components, and infusion accessories can be manufactured using 100% DEHP-free, phthalate-free, and latex-free medical grade compounds. Biocompatibility testing documentation compliant with ISO 10993 (covering cytotoxicity, systemic toxicity, sensitization, and hemocompatibility) is supplied upon request.
Our safety IV cannula features an automated passive safety mechanism integrated inside the catheter hub. As the stylet needle is withdrawn, a stainless-steel safety shield automatically locks over the sharp needle tip. Because activation requires no extra manual steps or clinical retraining, it completely prevents accidental needle-stick exposure and needle re-use during disposal.
We regularly execute export contracts under FOB, CIF, CFR, and DDP Incoterms. Containerized ocean freight is dispatched via Nhava Sheva (Mumbai) or Mundra ports, while urgent air shipments move through Indira Gandhi International Airport (DEL), New Delhi. Flexible payment structures—including irrevocable Letters of Credit (L/C at sight) and Telegraphic Transfer (T/T)—are available for qualified distributors and government tender contracts.
Prior to warehouse dispatch, every production lot undergoes rigorous multi-stage QA testing. Protocols include: barrel-to-plunger air and liquid leak testing (per ISO 7886-1), needle bonding pull force testing, bevel sharpness penetration force measurement, hub luer taper gauging (ISO 80369-7), biological indicator sterilisation validation, and particulate matter analysis.
Yes. We provide sample sets complete with batch Certificates of Analysis and technical specification sheets to support clinical trial evaluations, distributor quality assessments, and national ministry of health registration files. Contact our export desk to arrange courier dispatch.
Backed by over two decades of technical expertise, Lars Medicare Private Limited provides international buyers with a secure, highly competitive manufacturing base. By removing third-party supply chain brokers, our partners gain direct access to engineering teams, transparent lead times, and predictable containerized pricing.
Indian Headquarters: 136, 2nd Floor, Avtar Enclave, Paschim Vihar, New Delhi 110063, India.
Americas Office: 555 Industrial Dr. Suite 105, Milton, ON, Canada L9T 8K1.
Manufacturing Plant: Sultanpur, Opp. Sports Authority of India, Near Bahalgarh Chowk, Sonepat 131021, Haryana, India.
Our single-use medical devices are exported to over 100 countries across Europe, Latin America, the Middle East, Africa, the CIS region, and South-East Asia. We bring extensive experience in managing complex tender specifications, container consolidation, and international regulatory clearance requirements.
Whether you require factory-direct pricing for standard hypodermic syringes, custom safety IV cannula manufacturing, or regulatory support for national tenders, our expert team is ready to assist.